Target RWE的封面图片
Target RWE

Target RWE

生物技术研究

Durham,North Carolina 4,607 位关注者

#TargetRWE unifies real world data & advanced analytics in an integrated community, shifting the paradigm in healthcare.

关于我们

Acquired by Highlander Health in January 2025, Target RWE generates complete, longitudinal datasets with the power of advanced analytics and rigorous causal inference methodologies to uncover deep insights on unmet needs, disease progression, and the efficacy and safety of new treatments in the real world. With strong expertise in liver disease, gastroenterology, and dermatology, Target RWE’s multi-stakeholder model allows you to develop robust disease protocols to inform study objectives and endpoints. Our registries contain all relevant disease state variables, which when combined with our digital collection of patient and clinician reported outcomes and biosamples provide a framework for decisions on study entry criteria and site selection – reducing unnecessary procedures and costly protocol amendments.

网站
https://targetrwe.com
所属行业
生物技术研究
规模
51-200 人
总部
Durham,North Carolina
类型
私人持股
创立
2015
领域
Nonalcoholic Steatohepatitis、Hepatocellular Carcinoma、Inflammatory Bowel Disease、Primary Biliary Cholangitis、Immune-Mediated Inflammatory Skin Conditions、Chronic Hepatitis B、Asthma、Value Evidence、Patient data、Data Analytics、Causal Inference、Real world data、Real world evidence、Health Outcomes和Population Health Research

地点

  • 主要

    6409 Fayetteville Rd

    Ste 120, Box 377

    US,North Carolina,Durham,27713

    获取路线

Target RWE员工

动态

相似主页

查看职位

融资